Literature DB >> 31110390

Microalbuminuria and Its Risk Factors in Type 2 Diabetic Patients.

Sanjay Kumar Thakur1, Sukesh Purush Dhakal1, Shreeya Parajuli2, Anil Kumar Sah3, Suresh Prasad Nepal1, Bishnu Dutta Paudel1.   

Abstract

BACKGROUND: Diabetic nephropathy is one of the dreaded complications of diabetes leading to chronic kidney disease and end stage renal failure globally. Microalbuminuria is the most sensitive marker of early recognition of the diabetic nephropathy. This study was carried out to find out the prevalence and potential risk factors of microalbuminuria which is the marker of diabetic nephropathy among diabetes patients in Nepal.
METHODS: A cross-sectional study was conducted on a random sample of 227 in T2DM patients in private diabetic clinics and Bir hospital in Kathmandu. Data were collected using standard questionnaire format to collect demography, anthropometry, and laboratory assessment of, HbA1c, post prandial, fasting glucose and micro albumin in urine. Micro albuminuria was measured using early morning urine specimen. Micro albuminuria was considered positive when urinary albumin to creatinine ratio was found to be 30-300 mg/g creatinine in preferably an early morning or a spot urine sample. The entire lab test will be done by applying the internationally accepted standards of tools and techniques.Those that were reported >30mg/mL of micro albumin were considered as positive.
RESULTS: Out of total 217 diabetic patients, 56.2% (122/217) were male and 43.8% (95/217) were female. Among all age groups, maximum patients enrolled were between the age group 41 to 80 (95%).Of the total, 20% (44/217)) patientswereMA positive. A statistical significant association was seen between MA and BMI (p=0.029), duration of DM (p=<0.001, hypertension (p=<0.001, smoking (p=<0.001) and physical activity (p=<0.001).
CONCLUSIONS: Diabetic patients in Nepal have prevalence of 20.3% microalbuminurea. Hypertension, obesity, sedentary lifestyles, duration more than 5 years of illness are found the most important risk factors for the development of microalbuminurea in diabetes.     Keywords:  Mellitus; microalbuminuria; type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31110390     DOI: 10.33314/jnhrc.1620

Source DB:  PubMed          Journal:  J Nepal Health Res Counc        ISSN: 1727-5482


  5 in total

1.  Physical Training Is a Potential Modifier of Risk for Contrast-Induced Acute Kidney Injury in Diabetes Mellitus.

Authors:  Sheila M F Couto; Douglas I Machado; Carolina Conde; Vinicius C Silva; Adriana A Souza; Karina B Peres; Beatriz A Brandi; Maria De Fátima F Vattimo
Journal:  Biomed Res Int       Date:  2020-11-17       Impact factor: 3.411

2.  Factors Associated with Chronic Kidney Disease in Patients with Type 2 Diabetes in Bangladesh.

Authors:  Sheikh Mohammed Shariful Islam; Masudus Salehin; Sojib Bin Zaman; Tania Tansi; Rajat Das Gupta; Lingkan Barua; Palash Chandra Banik; Riaz Uddin
Journal:  Int J Environ Res Public Health       Date:  2021-11-23       Impact factor: 3.390

3.  Spot urinary microalbumin concentration, metabolic syndrome and type 2 diabetes: Tehran lipid and glucose study.

Authors:  Zahra Gaeini; Zahra Bahadoran; Parvin Mirmiran; Reza Norouzirad; Asghar Ghasemi; Fereidoun Azizi
Journal:  BMC Endocr Disord       Date:  2022-03-08       Impact factor: 2.763

4.  Poor glycemic control, cardiovascular disease risk factors and their clustering among patients with type 2 diabetes mellitus: A cross-sectional study from Nepal.

Authors:  Mahesh Kumar Khanal; Pratiksha Bhandari; Raja Ram Dhungana; Yadav Gurung; Lal B Rawal; Gyanendra Pandey; Madan Bhandari; Surya Devkota; Maximilian de Courten; Barbora de Courten
Journal:  PLoS One       Date:  2022-07-25       Impact factor: 3.752

5.  Incidence of Microalbuminuria and Factors Affecting It in Patients With Type 2 Diabetes Mellitus.

Authors:  Tayyab Mumtaz Khan; Fatima Kausar Nawaz; Muhammad Sikandar Karim; Zubair Shafique; Muhammad Saad Anwar; Omer Usman
Journal:  Cureus       Date:  2022-07-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.